![Kevin Leach](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Leach
Corporate Officer/Principal chez
Massachusetts Institute of Technology
Profil
Kevin Leach currently works at Massachusetts Institute of Technology, as Member.
Dr. Leach also formerly worked at Travere Therapeutics, Inc., as Senior Director-Translational Research and F-Star Therapeutics, Inc. (United States), as VP-Nonclinical & Translational Research.
Dr. Leach received his undergraduate degree from the University of Richmond.
Postes actifs de Kevin Leach
| Sociétés | Poste | Début |
|---|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Kevin Leach
| Sociétés | Poste | Fin |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| SPRING BANK PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Kevin Leach
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of Richmond
 University of Richmond Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Choisissez Zonebourse 
